Sante DICOM Viewer Pro DICOM File Parser out-of-bounds write

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
8.1$0-$5k0.00

Summaryinfo

A vulnerability classified as critical was found in Sante DICOM Viewer Pro. This affects an unknown part of the component DICOM File Parser. The manipulation results in out-of-bounds write. This vulnerability is known as CVE-2023-39431. It is possible to launch the attack remotely. No exploit is available. Upgrading the affected component is advised.

Detailsinfo

A vulnerability was found in Sante DICOM Viewer Pro (Medical Device Software) (version unknown). It has been classified as critical. Affected is an unknown function of the component DICOM File Parser. The manipulation with an unknown input leads to a out-of-bounds write vulnerability. CWE is classifying the issue as CWE-787. The product writes data past the end, or before the beginning, of the intended buffer. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:

Sante DICOM Viewer Pro lacks proper validation of user-supplied data when parsing DICOM files. This could lead to an out-of-bounds write. An attacker could leverage this vulnerability to execute arbitrary code in the context of the current process.

The weakness was published 10/19/2023 as icsma-23-285-01. The advisory is available at cisa.gov. This vulnerability is traded as CVE-2023-39431 since 09/12/2023. Successful exploitation requires user interaction by the victim. The technical details are unknown and an exploit is not available.

Upgrading eliminates this vulnerability.

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Productinfo

Type

Vendor

Name

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 8.3
VulDB Meta Temp Score: 8.1

VulDB Base Score: 8.8
VulDB Temp Score: 8.4
VulDB Vector: 🔍
VulDB Reliability: 🔍

CNA Base Score: 7.8
CNA Vector (ICS-CERT): 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Out-of-bounds write
CWE: CWE-787 / CWE-119
CAPEC: 🔍
ATT&CK: 🔍

Physical: Partially
Local: Yes
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Timelineinfo

09/12/2023 🔍
10/19/2023 +37 days 🔍
10/19/2023 +0 days 🔍
10/19/2023 +0 days 🔍

Sourcesinfo

Advisory: icsma-23-285-01
Status: Confirmed

CVE: CVE-2023-39431 (🔍)
GCVE (CVE): GCVE-0-2023-39431
GCVE (VulDB): GCVE-100-242970

Entryinfo

Created: 10/19/2023 21:17
Changes: 10/19/2023 21:17 (51)
Complete: 🔍
Cache ID: 216::103

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Do you need the next level of professionalism?

Upgrade your account now!